(b)(4).Samples received: 3 unopened racepacks.Analysis and results: there are no previous complaints of this code-batch.We manufactured and distributed in the market (b)(4) units of this code-batch.There are no units in our stock.We have received three closed samples.We have tested the knot pull tensile strength of the samples received and the results fulfill the requirements of the european pharmacopoeia (ep): (b)(4) in average and (b)(4) in minimum (ep requirements: (b)(4) in average and (b)(4) in minimum).Additionally, needle attachment strength test has been conducted on the closed samples received in order to discard a faulty needle attachment during manufacturing process that could cause splitting/fraying in the thread.The needle attachment strength results fulfil the requirements of the european pharmacopoeia (ep): (b)(4) in average and (b)(4) in minimum (ep requirements: (b)(4) in average and (b)(4) in minimum).We have not found splitting on thread surface on the closed samples received before and after performing tests.Reviewed the batch manufacturing record, this product had a normal process and the results during the process fulfill usp/ep and b.Braun surgical requirements.As indicated in the instructions for use of the product, when working with optilene suture material, great care should be taken to avoid any crushing or crimping damage of the monofilament by instruments such as forceps or needle holders.Final conclusion: although the results of the closed samples received fulfil the specifications of european pharmacopoeia/ b.Braun surgical specifications, we take note of this incidence in order to assess if new or additional actions are needed.Corrective/preventive actions: according to our internal procedures, there is no need to establish corrective or preventive actions.Nevertheless, this complaint is recorded for trending analysis to assess if actions are needed in the future.
|